South Korea
· Delayed Price · Currency is KRW Chabiotech Statistics
Total Valuation
Chabiotech has a market cap or net worth of KRW 1.18 trillion. The enterprise value is 2.11 trillion.
| Market Cap | 1.18T |
| Enterprise Value | 2.11T |
Important Dates
The last earnings date was Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Chabiotech has 75.96 million shares outstanding. The number of shares has decreased by -30.95% in one year.
| Current Share Class | 75.96M |
| Shares Outstanding | 75.96M |
| Shares Change (YoY) | -30.95% |
| Shares Change (QoQ) | +41.47% |
| Owned by Insiders (%) | 13.75% |
| Owned by Institutions (%) | 10.09% |
| Float | 56.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.98 |
| PB Ratio | 1.48 |
| P/TBV Ratio | 7.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -18.11 |
| EV / Sales | 1.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.04 |
Financial Position
The company has a current ratio of 0.68, with a Debt / Equity ratio of 1.04.
| Current Ratio | 0.68 |
| Quick Ratio | 0.59 |
| Debt / Equity | 1.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.31 |
| Interest Coverage | -1.66 |
Financial Efficiency
Return on equity (ROE) is -18.42% and return on invested capital (ROIC) is -3.63%.
| Return on Equity (ROE) | -18.42% |
| Return on Assets (ROA) | -2.52% |
| Return on Invested Capital (ROIC) | -3.63% |
| Return on Capital Employed (ROCE) | -7.59% |
| Revenue Per Employee | 4.31B |
| Profits Per Employee | -419.25M |
| Employee Count | 278 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 20.68 |
Taxes
In the past 12 months, Chabiotech has paid 4.89 billion in taxes.
| Income Tax | 4.89B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.81% in the last 52 weeks. The beta is 0.38, so Chabiotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +4.81% |
| 50-Day Moving Average | 12,346.40 |
| 200-Day Moving Average | 11,414.65 |
| Relative Strength Index (RSI) | 71.83 |
| Average Volume (20 Days) | 648,713 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Chabiotech had revenue of KRW 1.20 trillion and -116.55 billion in losses. Loss per share was -1,880.26.
| Revenue | 1.20T |
| Gross Profit | 321.07B |
| Operating Income | -88.76B |
| Pretax Income | -138.93B |
| Net Income | -116.55B |
| EBITDA | -31.46B |
| EBIT | -88.76B |
| Loss Per Share | -1,880.26 |
Balance Sheet
The company has 337.53 billion in cash and 824.04 billion in debt, giving a net cash position of -486.51 billion or -6,405.21 per share.
| Cash & Cash Equivalents | 337.53B |
| Total Debt | 824.04B |
| Net Cash | -486.51B |
| Net Cash Per Share | -6,405.21 |
| Equity (Book Value) | 792.81B |
| Book Value Per Share | 4,319.42 |
| Working Capital | -372.92B |
Cash Flow
In the last 12 months, operating cash flow was -73.35 billion and capital expenditures -117.89 billion, giving a free cash flow of -191.25 billion.
| Operating Cash Flow | -73.35B |
| Capital Expenditures | -117.89B |
| Free Cash Flow | -191.25B |
| FCF Per Share | -2,517.87 |
Margins
Gross margin is 26.81%, with operating and profit margins of -7.41% and -9.73%.
| Gross Margin | 26.81% |
| Operating Margin | -7.41% |
| Pretax Margin | -11.60% |
| Profit Margin | -9.73% |
| EBITDA Margin | -2.63% |
| EBIT Margin | -7.41% |
| FCF Margin | n/a |
Dividends & Yields
Chabiotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 30.95% |
| Shareholder Yield | 30.95% |
| Earnings Yield | -9.91% |
| FCF Yield | -16.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2014. It was a reverse split with a ratio of 0.7262.
| Last Split Date | Jun 2, 2014 |
| Split Type | Reverse |
| Split Ratio | 0.7262 |
Scores
Chabiotech has an Altman Z-Score of 0.6 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.6 |
| Piotroski F-Score | 4 |